Shenzhen MagicRNA Biotechnology Co., Ltd
4 clinical trials · Sponsor
◉ Watch Shenzhen MagicRNA Biotechnology Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases (NCT07523282) | Shenzhen MagicRNA Biotechnology Co., Ltd | 2026-12-31 |
| Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG) (NCT07556120) | Shenzhen MagicRNA Biotechnology Co., Ltd | 2026-12-31 |
| Efficacy and Safety of HN2301 in Refractory Myasthenia Gravis(MG) (NCT06965309) | Shenzhen MagicRNA Biotechnology Co., Ltd | 2026-01-19 |
| Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs） (NCT06801119) | Shenzhen MagicRNA Biotechnology Co., Ltd | 2025-03-16 |
Track Shenzhen MagicRNA Biotechnology Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.